Biosimilars in Oncology TOOLKIT



Thank you for registering for the Biosimilars in Oncology webinar! Take the next step in overcoming some of the barriers to biosimilar implementation with these helpful resources. You can watch the webinar here.

  1. Sample Policy to Expedite Biosimilar Adoption
  2. Example Strategy for Biosimilar Adoption: Bhat S, et al. Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb. J Manag Care Spec Pharm 2020;26:410-416
  3. Managing and Understanding Payor Biosimilar Policy Changes
  4. Cost Simulation: McBride A, et al. Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma. J Med Econ 2020;23:28-36.
  5. Data Regarding Same-Day vs. Next-Day Pegfilgrastim
    1. Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients with Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin’s Lymphoma
    2. Safety of Administering Pegfilgrastim on the Final Day of 5-Fluorouracil Continuous Intravenous Infusion
    3. Dose-Adjusted EPOCH Therapy Quality and Cost Considerations Under an Alternate Payment Model 
    4. Incidence of Febrile Neutropenia Using Same-Day Versus Next-Day Pegfilgrastim in Patients with Gastrointestinal Cancers Treated with FOLFOX or FOLFIRI
    5. Safety and Efficacy of Same-Day Administration of Pegfilgrastim in Patients Receiving Chemotherapy for Gastrointestinal Malignancies
    6. Safety and Efficacy of Day 1 Versus Day 2 Administration of Pegfilgrastim in Patients Receiving Myelosuppressive Chemotherapy for Gynecologic Malignancies 
    7. Safety and Efficacy of Same-Day Administration of Pegfilgrastim in Patients Receiving Chemotherapy in Lung Cancer
    8. Efficacy of Same-Day Vs. Next-Day Pegfilgrastim for the Prevention of Chemotherapy-Induced Febrile Neutropenia
    9. Same Day Pegfilgrastim or Pegfilgrastim-cbqv Prophylaxis in Mini-CHOP Chemotherapy Based Regimens for Non-Hodgkin Lymphoma
    10. Evaluation of Same Day Pegfilgrastim or PFG-cbqv Prophylaxis in Chemotherapy Induced Febrile Neutropenia in Bendamustine Plus Rituximab and CHOP +/- R Regimens in Patients with Lymphoma and Chronic Lymphocytic Leukemia
    11. Similar Incidence of Febrile Neutropenia with Same-Day Versus Subsequent Day G-CSF Administration in Non-Hodgkin Lymphoma Patients Receiving R-CHOP Chemotherapy
    12. Safety of Same-Day Pegfilgrastim Administration in Metastatic Castration-Resistant Prostate Cancer Treated with Cabazitaxel with or without Carboplatin